CK LIFE Aktie

 

CK Life Sciences, a unit of Li Ka-shing-backed CK Group, plans to bring its cancer vaccine candidates to mainland China through a “fast track” channel as Beijing moves to accelerate early-stage drug development. “We are planning to run investigator-initiated trials [IITs], hopefully, in the next year,” CK Life Sciences' vice-president and chief scientific officer Dr Melvin Toh Kean-meng said in a recent interview. His comments came as CK Life Sciences set up Sequencio Therapeutics in Hong Kong......

CKLIFE SCIENCES (00775.HK) announced the establishment of its Scientific Advisory Board, a strategic body of independent experts from academia, clinical research, and industry. Its members include Ko Wing-man, former Secretary for Food and Health, Rina Hui, Clinical Professor and Director of the Centre of Cancer Medicine at the ......

CKLIFE SCIENCES (00775.HK) presented preclinical research data from its therapeutic cancer vaccine development series at the Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting, held successfully in National Harbor, State of Maryland, the US. The presentation highlighted significant progress in the development of canc......

CKLIFE SCIENCES (00775.HK) announced that its Polynoma will merge with TransCode Therapeutics (RNAZ.US), and they have entered into a share purchase and preferred stock financing agreement.Initially, CKLIFE SCIENCES will hold about 9.1% of TransCode's shares and receive non-voting preferred stock. Once all preferred shares a......

CK Life Sciences International is set to merge its subsidiary Polynoma with Nasdaq-listed TransCode Therapeutics, in a move expected to boost the pipeline of anticancer drugs, according to the biotech unit controlled by the Li Ka-shing family. The agreement paved the way for TransCode to acquire the parent company of Polynoma from DEFJ, an indirect wholly owned unit of CK Life, the latter said in a filing with the Hong Kong stock exchange after trading hours on Wednesday. In exchange, TransCode......

TransCode acquires 100% of the issued and outstanding interests of Polynoma from CK Life Sciences Concurrent equity investment of $25 Million from CK Life Sciences into TransCode TransCode expands its microRNA-based pipeline with Polynoma's Phase 3-ready seviprotimut-L, a novel polyvalent......

Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...

CKLIFE SCIENCES (00775.HK) announced that the Company will present new data from preclinical studies of investigational cancer vaccines at the 2025 American Association for Cancer Research (AACR) Annual Meeting in Chicago, USA. The said cancer vaccines target PRAME (Preferentially Expressed Antigen in Melanoma), PD-L1 (programme......

FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN CK LIFE SCIENCES HD-,10 LSI KYG2176J1058 AB/FROM ONWARDS 11.04.2025...

CKLIFE SCIENCES (00775.HK) resumed trading of its shares today (11th), and once leapfrogged as high as nearly 42% to a high of $0.68. The stock last printed at $0.61, up 27.08%, with 16.627 million shares traded, involving $10.8023 million.CKLIFE SCIENCES obtained promising early results in laboratory tests of its preclinical st......

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL CK LIFE SCIENCES HD-,10 LSI KYG2176J1058 BAW/UFN...

Instrument ID [6636] (LSI - KYG2176J1058) suspended...

At the request of CKLIFE SCIENCES (00775.HK), trading in the shares of the Company has been halted with effect from 9:00 a.m. on Thursday (10th) pending the release of an announcement by the Company. ~AAStocks Financial NewsWeb Site: www.aastocks.com...

CKLIFE SCIENCES (00775.HK) announced that trading in its shares has been halted since 9:00 am on Thursday (10th), with the reason still veiled.~AAStocks Financial NewsWeb Site: www.aastocks.com...

As at 24 March, the public float of CKLIFE SCIENCES (00775.HK) has been restored to above the minimum percentage of 25% prescribed under Rule 8.08(1)(a) of the Rules Governing the Listing of Securities on the Stock Exchange, according to CKLIFE SCIENCES' announcement. Currently, the shareholding of CKH HOLDINGS (00001.HK)/ L......

Largest shareholder, CK Life Sciences Int'l., (Holdings) Inc. agrees to conversion of debt into equity, removing all existing debt from Dogwood's balance sheet Largest shareholder, CK Life Sciences Int'l., (Holdings) Inc. agrees to conversion of debt into equity, removing all existing debt from Dogwood's balance sheet...

The company said the loss for 2024 could come in at HK$126.6 million (US$16.3 million) versus a profit of HK$17.3 million the previous year....